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Objectives We sought to perform the first systematic study of the natural history of chronic total arterial occlusions (CTOs)
in an experimental model.
Background Angioplasty of CTOs has low success rates. The structural and perfusion changes during CTO maturation, which
may adversely affect angioplasty outcome, have not been systematically studied.
Methods Occlusions were created in 63 rabbit femoral arteries by thrombin injection. Histology, contrast-enhanced mag-
netic resonance imaging, relative blood volume (RBV) index, and micro-computed tomography imaging were an-
alyzed at 2, 6, 12, and 18 to 24 weeks.
Results Early changes were characterized by an acute inflammatory response and negative arterial remodeling, with
70% reduction of arterial cross-sectional area (CSA) from 2 to 6 weeks. Intraluminal neovascularization of the
CTO occurred with a 2-fold increase in total (media  intima) microvessel CSA from 2 to 6 weeks (0.014 
0.002 mm2 to 0.023  0.005 mm2, p  0.0008) and a 3-fold increase in RBV index (5.1  1.9% to 16.9 
2.7%, p  0.0008). However at later time periods, there were significant reductions in both RBV (3.5  1.1%,
p  0.0001) and total microvessel CSA (0.017  0.002 mm2, p  0.011). Micro-computed tomography imag-
ing demonstrated a corkscrew-like recanalization channel at the proximal end at 6 weeks that regressed at later
time points. These vascular changes were accompanied by a marked decrease in proteoglycans and accumula-
tion of a collagen-enriched extracellular matrix, particularly at the entrance (“proximal fibrous cap”).
Conclusions This study is the first to systematically analyze compositional changes occurring during CTO maturation,
which may underlie angioplasty failure. Negative remodeling, regression of intraluminal channels, and CTO
perfusion, together with the accumulation of dense collagen, may represent important targets for novel
therapeutic interventions. (J Am Coll Cardiol 2009;53:1148–58) © 2009 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.09.064a
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lrterial chronic total occlusions (CTOs) in the coronary
nd peripheral vasculature are common and are associated
ith significant morbidity and adverse outcomes (1,2).
ercutaneous angioplasty procedural success rates for CTOs
rom the *Schulich Heart Programme, Sunnybrook Research Institute, Sunnybrook
ealth Sciences Centre, Toronto, Ontario, Canada; †St. Michael’s Hospital, To-
onto, Ontario, Canada; ‡Department of Medical Biophysics, University of Toronto,
oronto, Ontario, Canada; §McLaughlin Centre for Molecular Medicine, University
f Toronto, Toronto, Ontario, Canada; and Department of Pathology, University
ealth Network, Toronto, Ontario, Canada. Dr. Jaffe is a Research Fellow of the
eart and Stroke Foundation of Canada. This study was funded by the Canadian
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008, accepted September 4, 2008.re much lower than in stenosed-but-patent arteries, pri-
arily due to failure of guidewire crossing through the
cclusion (3–5), resulting in either referral of these patients
or bypass surgery or avoidance of revascularization. Angio-
lasty success rates are inversely related to the age of the
cclusion (1), suggesting that difficulties in crossing CTOs
ith guidewires are due to specific composition and physical
haracteristics of the CTO that change over time. To date,
he pathological basis for angioplasty failure in CTOs has
ot been clearly defined. Only a small number of human
TO pathological specimens have been reported in the
iterature (6,7), which are limited by uncertain assessment of
he age of the occlusion and inattention to specific geo-
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March 31, 2009:1148–58 Natural History of CTOraphic levels within the CTO. Neovascularization of the
TO lumen may constitute an important aspect of the
aturation process. Previous studies of human arteries and
xperimental CTOs have suggested that the presence of
icrovessels within the CTO lumen may facilitate guide-
ire crossing, either as a direct pathway or by enhancing
avorable changes in the composition of the surrounding
xtracellular matrix (6–8). Thus, the objective of this study
as to perform an in-depth and detailed analysis of the
aturational changes occurring within a nonatheroscle-
otic CTO model that is initiated by an acute thrombus
ormation. To accurately assess the spatial and temporal
hanges in the specific components, we used an approach
hat combined histology, specific matrix stains, and com-
lementary in vivo and ex vivo imaging.
ethods
he occlusion model. Animal experiments conformed to
he “Position of the American Heart Association on
esearch Animal Use.” Approval for experiments was
btained from St. Michael’s and Sunnybrook Hospital
nimal Care Committees. Arterial occlusions were cre-
ted in 38 male New Zealand White rabbits (63 arteries,
harles River Canada, St. Constant, Quebec, Canada),
eighing 3.0 to 3.5 kg, by injection of thrombin solution
100 IU, Millipore cat. no. 82-036-3, Kankakee, Illinois)
nto an isolated femoral artery segment, as previously
escribed (9). Ligatures were maintained up to 60 min to
nsure a persistent occlusion. Animals were then returned
o their cage and fed a regular diet. Animals were
acrificed at 2, 6, 12, 18, and 24 weeks (range 12 to 20
TOs/time point) after creation of the CTO. Because
here were no quantitative or qualitative differences in
ny of the analyses between 18- and 24-week-old CTOs,
he results of these 2 groups were combined. Magnetic
esonance imaging (MRI) imaging was performed on the
nimals immediately before they were sacrificed, which
as followed by ex vivo micro-computed tomography
CT) imaging and histological analysis.
RI. We used MRI to quantify blood volumes within the
TO lumen as a measurement of functioning neovascular
icrovessels. The MRI studies were performed in 30 rabbits
30 arteries, 5 to 10 CTOs/time point) on a 3T GE Excite
canner (GE Healthcare, Milwaukee, Wisconsin) by the use
f a custom (5  3 cm) surface coil secured over the tissue
round the occluded femoral artery. Occlusions were imaged
ith the use of an elliptic-centered fast spoiled gradient echo
equence (repetition time/echo time/  8.3/2.1/30°, 31.25-
Hz receive bandwidth, resolution of 0.25 mm in plane, 0.6
m through plane). The elliptic ordering of acquisition pro-
ures most of the contrast during the first several seconds and,
hus, the images are more representative of the contrast close to
he start of the imaging.
T1-weighted images were obtained 16 s after the injection
f 0.05 ml/kg Clariscan (Feruglose, GE Healthcare, Chalfont, (nited Kingdom). To maintain an
dequate signal-to-noise ratio,
ach data point was consecutively
veraged 4 times, yielding an im-
ging time of 216 s. Clariscan
Nycomed Imaging, Oslo, Nor-
ay) remains inside blood vessels
nd reflects relative blood volume
RBV) within the CTO lumen
10,11), serving as a surrogate for
erfusion. Regions of interest were
elected in the proximal part of the
TO on each of the T1-weighted
R images to calculate average
ignal intensity. Relative distribu-
ion volume of Clariscan was de-
ived from the ratio of tissue signal
ntensity in the region of interest
ompared with the vessel segment
mmediately proximal to the CTO (12).
icro-CT imaging. Intravenous heparin (3,000 U) was
dministered to the animals before they were sacrificed to
revent blood coagulation in the microvasculature. Mi-
rofil (30 ml, Flowtech, Carver, Massachusetts) was
njected into the abdominal aorta at a pressure of 90 mm
g, as measured by a handheld manometer. The femoral
rteries were fixed in formalin for 48 h, embedded in 1%
/w agarose gel, and imaged in the micro-CT (MS-8,
E Medical Systems, London, Ontario). A 17-m
esolution was achieved (13). Three-dimensional cone
eam CT datasets were acquired in 2.5 h with 905 views
t 35 m. X-ray source of voltage 80 kvp and a 90 mA
eam current were used. A 3-dimensional data volume
as reconstructed at 17 m with use of the Feldkamp
lgorithm for cone beam CT geometry software. Images
ere exported into Amira (Mercury Computer Systems,
helmsford, Massachusetts) as series of axial slices and
ere volume-rendered by setting the threshold slightly
igher than the Hounsfield units of the Microfil (Flow-
ech) to display the vasculature.
istological analysis. After micro-CT imaging, the femoral
rteries were cut into sequential 2-mm cross sections
hroughout the length of the occluded segment. In some
nstances, vessels were sectioned longitudinally. Sections
ere routinely stained with hematoxylin and eosin and
ovat stains. In 80% of CTOs, 3 cross sections
ithin the CTO were analyzable. The proximal and
istal CTO segments were defined as the sections within
he CTO that were immediately adjacent to the patent
rtery at the entry and exit site, respectively. All other
ections were defined as the body of the CTO and
easurements within this segment were averaged.
Morphometric measurements were performed with the
mage J software (National Institutes of Health, Bethesda,
aryland). Lumen, media, and vessel cross-sectional area
Abbreviations
and Acronyms
CSA  cross-sectional area
CT  computed
tomography
CTO  chronic total
arterial occlusion
hpf  high power field
IEL  internal elastic
lamina
MRI  magnetic resonance
imaging
PCI  percutaneous
coronary intervention
PSR  picrosirius red
RBV  relative blood
volumeCSA) were measured in Movat-stained sections. Integrity
o
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c
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Natural History of CTO March 31, 2009:1148–58f the internal elastic lamina (IEL) was quantified by
alculating the percentage of disrupted IEL (disrupted IEL
ircumference/overall IEL circumference  100). Movat-
tained sections also were used to calculate relative percent
Figure 1 Quantitative Analyses of Temporal Changes in Vessel
(A) Arterial cross-sectional area (within the external elastic lamina). (B) Luminal c
(D) Lumen lipid content. Significant reduction in arterial and luminal cross-sectiona
points, whereas lipid content increased at later time points.reas of 3 components of the CTO (lipid, microvessels, and
eointimal tissue) at the 4 time points.
Inflammation was graded separately by 2 observers
R.J., J.B.) for the intima and media on a scale of 1 to 4
logy
ctional area (within the internal elastic lamina). (C) Inflammation score.
occurred after 2 weeks. Inflammatory score was greater during the early timeHisto
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March 31, 2009:1148–58 Natural History of CTOy counting the number of white blood cells within a
igh-power field (hpf) (200 magnification): 0/hpf, 1 to
0/hpf, 21 to 50/hpf, and 50/hpf. Analysis of collagen
ontent was performed with picrosirius red (PSR) stain-
ng. Qualitative collagen analysis was performed on PSR-
tained slides by orientation-independent polarized microscopy
LC-PolScope, CRI Inc., Woburn, Massachusetts) (14).
uantitative analysis of collagen content was performed by
orphometric measurement of the percentage of lumen area
tained with PSR (15). Proteoglycan content was analyzed
ualitatively in Alcian blue-stained cross sections.
The CTO microvessels within the occluded lumen
ere identified on Movat-stained sections as vascular
tructures lined with endothelial cells and with the
ccasional presence of medial smooth muscle cells
SMCs). These structures were often filled with Microfil.
n some cases, red blood cells also were evident. Endo-
helial cell identification was confirmed with CD31
mmunohistochemistry on selected slides. In each cross
ection, the number of microvessels, the CSA of each
ndividual microvessel, and the overall microvessel (in-
ima  media) CSA within the cross section were
easured morphometrically with the use of Image J
SW10 R8 x5.movat.jpg
A
C
2 wks
12 wks
* *
*
L
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L
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Figure 2 Movat-Stained Sections Showing Temporal Changes in
Representative histological sections of occlusions at 2 (A), 6 (B), 12 (C), and 24
ences in calibration). Microvessels (indicated by *) were maximal at 6 weeks with aoftware (National Institutes of Health). For the identi-
cation of luminal cell types, immunohistochemistry was
erformed with the use of specific antibodies directed
gainst macrophages (RAM 11, Dako, Mississauga, On-
ario, Canada) and SMCs (alpha-SMC actin and desmin,
lone DE-U-10, Sigma, St. Louis, Missouri).
tatistics. Data were analyzed by analysis of variance with
he use of the generalized linear model procedure (proc
LM) in SAS (version 8.2, SAS Institute, Cary, North
arolina). Values are presented as mean  SEM. For the
omparison of means at each time point, least squares means
nd SEM estimates were calculated by SAS proc GLM,
ith the use of the Tukey-Kramer adjustment of p values for
ultiple comparisons. A value of p  0.05, adjusted for
ultiple comparisons, was considered statistically significant.
esults
emodeling changes. Arterial CSA, within the external
lastic lamina, rapidly decreased from 1.146  0.096 mm2
t 2 weeks to 0.327  0.026 mm2 at 6 weeks (p  0.0001),
ith further (nonsignificant) reduction to 0.223  0.012
m2 at 18 to 24 weeks (Figs. 1 and 2). Lumen CSA, within
he IEL, concomitantly decreased from 0.310 0.014 mm2
B
D
6 wks
24 wks
**
*
*
*
* **
*
**
*
*
*
*
L
M
Ad
L
M
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sel Size and Intraluminal Microvessels
(D). There was marked reduction in vessel size at 6 weeks (note the differ-
se at the later time period. Ad  adventitia; L  lumen; M  media.Ves
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Natural History of CTO March 31, 2009:1148–58t 2 weeks to 0.108  0.005 mm2 at 18 to 24 weeks (p 
.0001). A progressive decrease of IEL integrity also was
bserved, with missing IEL increasing from 4.9  2.1% at
weeks to 16.2  2.8% at 18 to 24 weeks.
nflammatory, thrombotic, and lipid changes. An acute
nflammatory infiltrate containing neutrophils and mono-
uclear cells peaked at 2 weeks with an inflammatory
core at 3.5  0.1 U, with progressive reductions at 6
eeks (2.7  0.2 U, p  0.0007) and 18 to 24 weeks (2.1
0.1 U, p  0.0001) (Fig. 1). There was a prominent
acrophage infiltration within the lumen at 2 weeks,
hich was mixed with thrombotic material in the lumen
Fig. 3). By 6 weeks, macrophages were still evident
ithin the occluded lumen, which no longer contained
hrombus, and these macrophages frequently were situ-
ted adjacent to microvessels. At later time points, only
are macrophages were present within the lumen. Mean
uminal macrophage number decreased from 2 weeks
280  44 cells) to 6 weeks (60  16 cells) and 12 weeks
18  7 cells) (p  0.002). At later time points there was
n accumulation of extracellular lipid with an increase in
Figure 3 Macrophage Immunostaining
Macrophage RAM-11 immunostaining at 2 weeks (A, magnified box region in B), 6
macrophage infiltration in the occluded lumen at 2 weeks that declines at later timhe relative luminal CSA of lipids from 2 weeks to the w8- to 24-week time period (0  0% to 20.7  3.4%,
 0.0001) (Fig. 1). At all time points, alpha-SMC
ctin-positive cells were present in the media of the vessel
Fig. 4). However, alpha-SMC actin–positive cells were
nly evident in the lumen of 2-week-old occlusions.
hese cells also were desmin negative, which led us to
dentify the cell type as a myofibroblast (16). At all later
ime points, the lumen cells were alpha-SMC actin–
egative, except in the media of luminal microvessels.
xtracellular matrix. At the 2-week time point, the
ormation of a proteoglycan-enriched extracellular matrix
ithin the thrombotic occlusion was observed (Fig. 5).
his matrix deposition occurred in a patchy pattern and
as first evident in the middle of 2-week-old occlusions
nd then was present at both the proximal and distal ends
f the CTO. The proteoglycan content progressively
ecreased beyond the early time points (2 and 6 weeks),
ith minimal or absent Alcian-blue staining at later time
oints. In contrast, lumen collagen content progressively
ncreased over time.
Collagen was not evident in 2-week old CTO. At 6
(C), and 12 weeks (D). There is a prominent perivascular
ts. *Microfil-filled microvessel. Arrows indicate internal elastic lamina.weeks
e poineeks, the relative lumen collagen content was 10.7  1.2%
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March 31, 2009:1148–58 Natural History of CTOnd increased to 15.0  1.1% at 18 to 24 weeks. Polscope
icroscopy demonstrated the increased collagen density
ithin the advanced CTO. Longitudinal sections of CTO
t the 12-week time period demonstrated a region of
ensely packed collagen at the entrance to the CTO, “the
roximal fibrous cap” (Fig. 6).
eovascularization and CTO RBV. Both structural and
unctional analyses of CTO neovascularization were per-
ormed. Microvessels were already apparent within the
ntima and media as early as the 2-week time point. Total
icrovessel CSA was 3-fold greater in the occluded lumen
han in the media at all time points. Total microvessel CSA
ncreased 2-fold within the occlusion from 2 to 6 weeks
0.014  0.002 mm2 to 0.023  0.005 mm2, p  0.0008)
ogether with a 3-fold increase in the size of individual
ntraluminal microvessels (0.0016 0.0001 mm2 to 0.0049
.0007 mm2, p 0.0001) (Fig. 7). These structural changes
ere accompanied by a 3-fold increase in CTO RBV by
RI (5.1  1.9% to 16.9  2.7%, p  0.0008) (Fig. 8).
At later time points (both 12 and 18 to 24 weeks), there
as a significant reduction in intraluminal CTO neovascu-
Figure 4 Alpha-SMC Actin Immunostaining
Alpha-smooth muscle cell (SMC) actin staining at 2 (A, magnified box region in B),
small microvessels within the lumen stain positively at all time points. The SMC a
Arrows indicate internal elastic lamina.arization. At 18 to 24 weeks, there was a 79% reduction in cBV relative to 6 weeks (3.5  1.1%, p  0.0001) (Fig. 8),
ccompanied by a marked decrease in total microvessel CSA
0.017  0.002 mm2, p  0.011) (Fig. 7). There was a
ignificant correlation between RBV and total microvessel
SA (r  0.40, p  0.03).
Micro-CT imaging demonstrated temporal and spatial
ifferences in the vascular geometry. At the 2-week time
oint, the entrance appeared blunt, with a minimal amount
f poorly defined channels extending into the soft thrombus
Fig. 9). At this time point, extravascular collaterals are
lready present. At 6 weeks, intraluminal recanalization
hannels with a “corkscrew-like” appearance were present at
he proximal part of the occlusion. The endoluminal chan-
els within the proximal portion were on the order of 50 m
n diameter. The midsection typically illustrated little con-
rast perfusion, with channels appearing discontinuous,
aking tracking of the vessels more difficult. At the late
ime point, there was regression of the proximal recanaliza-
ion channel, and the entrance appeared blunt. In addition,
cans also showed several small, highly fragmented channels
ppearing within the lumen, suggesting an apparent loss of
, 12 (D), and 18 weeks (E). The medial layer of the main vessel and media of
sitive cells are evident in the lumen at 2 weeks but not at later time points.6 (C)
ctin-poontinuity of the microvessels.
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n this study, we identified 3 stages of CTO maturation:
arly (2 weeks), intermediate (6 to 12 weeks), and
dvanced (18 to 24 weeks). The early stage was charac-
erized by an acute inflammatory response to vessel injury
nd initial patchy formation of extracellular matrix and
yofibroblast infiltration within the thrombotic occlu-
ion. This immature extracellular matrix was character-
Figure 5 Temporal Changes in Vessel Size and Composition of
(A to C) At 2 weeks; (D to F) at 24 weeks. (A and D) Movat-stained sections sho
bars). (B and E) Alcian blue-stained sections with prominent blue staining in the o
no staining is shown at 24 weeks (E). In contrast, picrosirius red-stained sections
prominence at 24 weeks (white staining) (F). Abbreviations as in Figure 2.
LPFC
M
EEL
EEL
A
Figure 6 Proximal Fibrous Cap
(A) Elastic trichrome-stained longitudinal section of 12-week-old chronic total arter
(B) Greater magnification of CTO origin. Arrows point to fragmented IEL. Green ind
external elastic lamina; other abbreviations as in Figure 2.zed by abundant proteoglycan content and low collagen
ensity. During the initial part of the intermediate stage
6 weeks), the CTO had undergone marked negative
rterial remodeling, IEL disruption, and intraluminal
eovascularization, accompanied by increased CTO per-
usion. During the latter intermediate stage (12 weeks),
icrovessels and relative blood volume within the CTO
ere already decreasing, which persisted into the ad-
xtracellular Matrix
arked decrease in size of vessel at 24 weeks (note the difference in calibration
d lumen and adventitia, indicating proteoglycan-rich matrix at 2 weeks (B), but
d F) under polarized light show the absence of collagen at 2 weeks (C) with
PFC
L
lusions (CTO) showing proximal fibrous cap (PFC) at the entrance of the CTO.
collagen. Also note disruption of media (M) at deeper levels of CTO. EEL the E
w a m
cclude
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March 31, 2009:1148–58 Natural History of CTOanced stage. The decreased perfusion in advanced CTO
ime points coincided with an increase in luminal colla-
en density and proteoglycan depletion.
The maturation of CTO represents a form of wound
ealing that is characterized by replacement of an initially
roteoglycan-rich extracellular matrix into a collagen-
ich scar at later time points. This pattern of healing is
nalogous to similar responses occurring after skin dam-
ge or various forms of arterial wall injury. However, the
obust intraluminal neovascularization response seems
nique to occluded vessels (both veins and arteries).
idirectional thrombus formation is considered an essen-
ial component of the initiating event in the pathogenesis
f human CTO development (1). Our experimental
odel specifically addresses the organization of thrombus
ithin the arterial occlusion as a critical determinant of
TO maturation. Previous studies of thrombus organi-
ation have been almost exclusively limited to veins (17).
Initially, the freshly-formed thrombus contains plate-
ets and erythrocytes within a fibrin mesh, which is
ollowed by invasion of acute inflammatory cells (18).
ndothelial cells also invade the fibrin lattice and form
ube-like structures and microvessels within the organiz-
ng thrombi (17,19). There are few published data on the
rocess of microvessel formation in arterial thrombi,
hich may differ from the process of venous neovascu-
arization. In one study, it was reported that arterial
hrombi recanalize less frequently and to a lesser extent
han venous thrombi. The behavior of venous cells may
lso differ substantially from their arterial counterparts
20,21).
Inflammation is known as a potent trigger of neovas-
ularization (22,23) and appeared to play an important
ole in our model. The neovascularization of CTO was
receded by an acute inflammatory response with prom-
Figure 7 Microvessel Area
There were significant increases in both total and individual microvessel (MV) cross-se
*p  0.05 versus 12 weeks; †p  0.001 versus 2 weeks; ‡p  0.0001 versus 2nent macrophage infiltration, particularly in perivascular tegions. Previous studies have similarly shown high
oncentrations of macrophages in regions of recanaliza-
ion in spontaneous human thrombi and in experimental
nimal arterial thrombi (24,25). Srivatsa et al. (6) likewise
eported that microvessel content in human coronary
TOs correlated with degree of inflammation.
Our study provides several factors in support of a
iologic basis for the clinical observation of increased
uidewire failure to cross older CTOs. The physical
roperties identified by our study include marked nega-
ive remodeling that resulted in approximately 80%
eduction in the overall size of the vessel by 6 weeks. This
ould potentially increase the difficulty of maintaining an
ntraluminal position of the guidewire. Moreover, for the
rst time, we have shown anatomic evidence of a “prox-
mal fibrous cap,” a thickened structure at the entrance of
he CTO containing particularly densely-packed colla-
en. Although collagen is present throughout the CTO,
ts prominence within the proximal fibrous cap likely acts
s a distinct physical barrier to access the CTO.
The biological composition of a CTO also changes
ver time. Occlusions that were 2 weeks of age were
haracterized by a proteoglycan-rich matrix that is rela-
ively soft and easy to traverse. At the later time points,
roteoglycans had been replaced by collagen, which has
onsiderably different biomechanical properties that resist
uidewire penetration. Prominent temporal changes in
TO perfusion also were evident. Despite the absence of
ow by angiography (because of its limited resolution of
pproximately 200 microns), contrast-MRI showed sig-
ificant differences in RBVs, a surrogate for perfusion, at
he various time points. There were transient and marked
ncreases in microvessel CSA and RBV from 2 to 6
eeks, followed by reductions to low levels at the 2 later
l area (CSA) at 6 weeks compared with all other time points.
s; §p  0.05 versus 18 to 24 weeks; #p  0.02 versus 18 to 24 weeks.ctiona
weekime points.
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Natural History of CTO March 31, 2009:1148–58These findings were supported by the micro-CT im-
ges, which showed a prominent tapering “corkscrew-
ike” vascular structure in the proximal part of the CTO.
he description of a tapering entrance of CTOs at
oronary angiography has been correlated with successful
rossing (7). However, this vascular structure regressed
nd was not visible at later time points. In addition, there
lso was fragmentation of intraluminal microvessels evi-
ent at the later time points. The discontinuity of the
icrovascular network and reduced CTO perfusion rep-
esent an unfavorable topography for guidewire crossing,
articularly with the increased rigid collagen-rich com-
osition in the intervening extracellular matrix at these
Figure 8 CTO RBV by MRI
(A) There was a marked (3-fold) increase in RBV at 6 weeks that decreased at the
0.002 versus 12 weeks; †p  0.001 versus 2 weeks; ‡p  0.0001 versus 18 to
sions at 4 different time points: 2 (B), 6 (C), 12 (D), and 18 weeks (E). Red arro
denotes representative regions of interest used to calculate blood volume in proxi
weeks relative to other time points indicates a greater concentration of Clariscan
imaging; RBV  relative blood volume; other abbreviations as in Figure 6.ater time points. tOur finding of a prominent microvessel network within
he CTO, despite the absence of perfusion by angiography,
s in agreement with human pathological studies (6,7).
ntraluminal neovascularization of the CTO may facilitate
uccessful guidewire crossing (6–8). On the basis of our
easurements of individual microvessel CSA, it is doubtful
hat conventional guidewires (360-micron diameter) actu-
lly use an individual microvessel for crossing. However, it
s possible that groups of microvessels in close proximity to
ach other or altered tissue compliance characteristics in a
ighly perfused segment may facilitate guidewire crossing.
he ability to detect the presence of microvessels and
nhance their formation may underlie future diagnostic and
time points, indicating maximum blood volume (and perfusion) at 6 weeks. *p 
eks. Representative images of Clariscan-enhanced MRI of chronic total occlu-
TO entrance point; blue arrow  CTO exit point. Yellow ellipse shown in (A)
gion of the lesion. The diffusely increased signal intensity within the CTO at 6
ence, an increased blood volume at this time point. MRI  magnetic resonancelater
24 we
w  C
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March 31, 2009:1148–58 Natural History of CTOelevance to human CTOs. Although CTOs are com-
on and difficult to treat with percutaneous coronary
ntervention (PCI), data from human pathological stud-
es are sparse and anecdotal. A relevant animal model is
ecessary for systematic analysis of the process of CTO
aturation and development of innovative therapeutic
pproaches. Our experimental model does have limita-
ions because it lacks an atherosclerotic substrate and
alcification that may potentially impact the CTO mat-
ration process. However, it recreates many features that
ave been recognized in the natural history of CTO (1),
ncluding an initial thrombotic occlusion, acute inflam-
atory response, negative arterial remodeling, and the
resence of microvessels and collagen-rich fibrous tissue.
ur study is the first to systematically document the
emporal changes during the process of CTO maturation
hat may underlie the difficulty in performing PCI in
24 weeks
Distal
Proximal
C
Proximal
Distal
A
2 weeks
Figure 9 Temporal Changes in the CTO Entrance Channel
Representative micro-computed tomography images of occlusions at 2 (A), 6 (B),
At 2 weeks a blunt, poorly formed entrance region can be observed. At 6 weeks, r
later time points (24 weeks), there is regression of the recanalization channel and
within the lumen identified by white arrowheads in (C). Red arrows signify the pro
Abbreviations as in Figure 6.hese lesions. Importantly, this study also correlated cndings from noninvasive imaging with histological data,
hus laying the groundwork for future studies to examine
he predictive value of imaging in selecting patients for
CI in addition to more complex atherosclerotic animal
odels.
linical implications. The pathology and interventional
uccess rates of CTO are quite different at various time
oints. Our findings of decreased vascular perfusion and
ntraluminal neovascularization in concert with collagen
ccretion at later time points that are typically characterized
y very low success rates have important clinical relevance.
irst, they offer rational targets for improving success rates,
uch as altering collagen content by enzymatic digestion
9,26) and/or enhancing intraluminal microvascular net-
ork formation; second, our study supports development of
oninvasive imaging modalities to improve tissue character-
zation and identification of favorable and unfavorable lesion
Proximal
Distal
6 weeks
B
D
Control
4 weeks (C). A high magnification view of the entrance is shown in each insert.
lization channels are present with a “corkscrew-like” appearance. However, at
ntrance appears blunt with several small, highly fragmented channels appearing
and distal edges of the occlusion. A normal femoral artery is shown in (D).and 2
ecana
the e
ximalharacteristics as part of pre-procedure revascularization
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Natural History of CTO March 31, 2009:1148–58lanning. The significance of CTO blood volume measure-
ents as a predictor of CTO crossing requires validation in
uman coronary CTO studies. Plans are underway to
oninvasively image human CTO for blood volume mea-
urements with the use of MR contrast reagents before
ttempts at revascularization are made. Further study is
equired to determine whether transformation of advanced
TO structural characteristics to those of an immature
cclusion, by induction of microvessel formation and/or
egradation of collagen content within the extracellular
atrix, will enhance clinical CTO percutaneous revascular-
zation success rates.
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